One of the biggest problems with brain cancer treatment is that only a limited amount of chemotherapy drugs make it through. See, our brain’s blood vessels are tightly lined with cells to keep out toxins and pathogens. The bad news is that it also hinders medicine from reaching tumors. A team of French scientists have recently tested a promising answer to that issue: an ultrasound implant that they designed to temporarily make this “blood-brain barrier” permeable. They ran a pilot with 15 patients suffering from glioblastoma, an aggressive form of brain cancer, and results showed that their technique successfully allowed more medicine to pass through.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.
When Sara Morales found out two years ago that she had a rare bone cancer, it felt like the cruelest kind of déjà vu. The 34-year-old Lower East Side resident was at the time still […]
Researchers based in Dublin have created a process to support 3D printing of new bone material – which might give those that require bone grafts more options. The research could be used to regenerate large defects […]
EurekAlert – Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers. […]